Literature DB >> 33479250

Transcriptional responses of Candida glabrata biofilm cells to fluconazole are modulated by the carbon source.

Rosana Alves1, Stavroula L Kastora2, Alexandra Gomes-Gonçalves1, Nuno Azevedo3, Célia F Rodrigues3,4, Sónia Silva3, Liesbeth Demuyser5,6, Patrick Van Dijck5,6, Margarida Casal1, Alistair J P Brown2,7, Mariana Henriques3, Sandra Paiva8.   

Abstract

Candida glabrata is an important human fungal pathogen known to trigger serious infections in immune-compromised individuals. Its ability to form biofilms, which exhibit high tolerance to antifungal treatments, has been considered as an important virulence factor. However, the mechanisms involving antifungal resistance in biofilms and the impact of host niche environments on these processes are still poorly defined. In this study, we performed a whole-transcriptome analysis of C. glabrata biofilm cells exposed to different environmental conditions and constraints in order to identify the molecular pathways involved in fluconazole resistance and understand how acidic pH niches, associated with the presence of acetic acid, are able to modulate these responses. We show that fluconazole treatment induces gene expression reprogramming in a carbon source and pH-dependent manner. This is particularly relevant for a set of genes involved in DNA replication, ergosterol, and ubiquinone biosynthesis. We also provide additional evidence that the loss of mitochondrial function is associated with fluconazole resistance, independently of the growth condition. Lastly, we propose that C. glabrata Mge1, a cochaperone involved in iron metabolism and protein import into the mitochondria, is a key regulator of fluconazole susceptibility during carbon and pH adaptation by reducing the metabolic flux towards toxic sterol formation. These new findings suggest that different host microenvironments influence directly the physiology of C. glabrata, with implications on how this pathogen responds to antifungal treatment. Our analyses identify several pathways that can be targeted and will potentially prove to be useful for developing new antifungals to treat biofilm-based infections.

Year:  2020        PMID: 33479250     DOI: 10.1038/s41522-020-0114-5

Source DB:  PubMed          Journal:  NPJ Biofilms Microbiomes        ISSN: 2055-5008            Impact factor:   7.290


  56 in total

Review 1.  A vaginal fluid simulant.

Authors:  D H Owen; D F Katz
Journal:  Contraception       Date:  1999-02       Impact factor: 3.375

Review 2.  The global problem of antifungal resistance: prevalence, mechanisms, and management.

Authors:  David S Perlin; Riina Rautemaa-Richardson; Ana Alastruey-Izquierdo
Journal:  Lancet Infect Dis       Date:  2017-07-31       Impact factor: 25.071

3.  In vivo Candida glabrata biofilm development on foreign bodies in a rat subcutaneous model.

Authors:  Soňa Kucharíková; Bram Neirinck; Nidhi Sharma; Jef Vleugels; Katrien Lagrou; Patrick Van Dijck
Journal:  J Antimicrob Chemother       Date:  2014-11-17       Impact factor: 5.790

Review 4.  Candida species: new insights into biofilm formation.

Authors:  Mayra Cuéllar-Cruz; Everardo López-Romero; Julio C Villagómez-Castro; Estela Ruiz-Baca
Journal:  Future Microbiol       Date:  2012-06       Impact factor: 3.165

5.  Growth, biofilm formation, antifungal susceptibility and oxidative stress resistance of Candida glabrata are affected by different glucose concentrations.

Authors:  Tzu Shan Ng; Mohd Nasir Mohd Desa; Doblin Sandai; Pei Pei Chong; Leslie Thian Lung Than
Journal:  Infect Genet Evol       Date:  2015-09-08       Impact factor: 3.342

Review 6.  Adherence and biofilm formation of non-Candida albicans Candida species.

Authors:  Sónia Silva; Melyssa Negri; Mariana Henriques; Rosário Oliveira; David W Williams; Joana Azeredo
Journal:  Trends Microbiol       Date:  2011-03-15       Impact factor: 17.079

7.  The glyoxylate cycle is required for fungal virulence.

Authors:  M C Lorenz; G R Fink
Journal:  Nature       Date:  2001-07-05       Impact factor: 49.962

Review 8.  Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action.

Authors:  H Vanden Bossche
Journal:  Curr Top Med Mycol       Date:  1985

9.  Current trends in candidemia and species distribution among adults: Candida glabrata surpasses C. albicans in diabetic patients and abdominal sources.

Authors:  Riad Khatib; Leonard B Johnson; Mohamad G Fakih; Kathleen Riederer; Laurence Briski
Journal:  Mycoses       Date:  2016-07-12       Impact factor: 4.377

10.  Niche-specific regulation of central metabolic pathways in a fungal pathogen.

Authors:  Caroline J Barelle; Claire L Priest; Donna M Maccallum; Neil A R Gow; Frank C Odds; Alistair J P Brown
Journal:  Cell Microbiol       Date:  2006-06       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.